live Trump says Iran agrees to keep Strait of Hormuz open, as Tehran confirm shipping access- Friday, 17 April
U.S. President Donald Trump and Iran’s Foreign Minister, Abbas Araghchi, have said the Strait...
China has overtaken the United States in the volume of medical research it publishes, showing a major shift in global scientific influence, according to the chief editorial leadership of Swiss-based scientific publisher Frontiers.
The publisher’s latest assessment suggests that China has now become the world’s largest source of medical research papers, reflecting years of rapid investment and expansion across its scientific system.
Fred Fenter, Frontiers’ chief executive editor, said China produced more than a million research papers in 2024, significantly outpacing U.S. output. He described the shift not as an isolated milestone but as part of a realignment in global scientific power, with emerging research systems becoming increasingly competitive with long-established Western institutions.
China’s surge is especially visible in fields such as oncology, where it has recently become the leading producer of cancer research publications. Analysts attribute this growth to extensive government funding, large-scale clinical trial capacity and a fast-developing biomedical infrastructure supported by steady growth in postgraduate training and personnel.
Recent international studies of research collaboration also show China quickly narrowing leadership gaps with the US., UK. and Europe, taking on more central roles in cross-border scientific teams. While China has not yet caught up in every measure, the trend indicates that its influence is expanding beyond sheer output to leadership in joint projects and high-impact research.
The transformation carries significant implications. Universities and private-sector research centres are reassessing how they collaborate with Chinese institutions, while pharmaceutical and biotech companies see China’s expanding clinical research system as a rising force in global drug development.
Governments, meanwhile, are debating the strategic ramifications of China’s growing scientific footprint - from research security to technology competitiveness.
The past 24 hours of the Russia-Ukraine war have seen a drastic escalation in both aerial bombardment and frontline losses.
U.S. President Donald Trump and Iran’s Foreign Minister, Abbas Araghchi, have said the Strait of Hormuz is now “completely open” to all commercial shipping for the remainder of the ceasefire period. Araghchi links the move to the ceasefire in Lebanon.
U.S. President Donald Trump said on Thursday that there was a "good chance" of a peace deal between Lebanon and Israel happening soon, after he announced a 10-day ceasefire between the two countries.
Russia published addresses of manufacturers allegedly producing drones or components for Ukraine on Wednesday (15 April), warning European countries against plans to step up UAV supplies to Kyiv.
U.S. President Donald Trump says Israeli and Lebanese leaders have agreed to a 10-day ceasefire that includes Hezbollah, raising cautious hopes of a pause in hostilities after weeks of escalating tensions.
A Chinese biotechnology company is stepping up efforts to combine artificial intelligence (AI) with advanced genetic testing in a bid to improve the success rates of in vitro fertilization (IVF), while also tapping into growing demand for fertility services.
Austria’s government on Friday approved plans to introduce a nationwide ban on social media use for children under the age of 14, alongside reforms to upper secondary school curricula aimed at boosting media literacy and Artificial Intelligence (AI) education from the 2027/28 academic year.
The UK Health Security Agency (UKHSA) said that as of Wednesday evening, it has identified six new cases of meningococcal disease in Kent, bringing the total of confirmed or suspected cases to at least 27.
The Scottish Parliament has voted against legalising assisted dying, ending a years-long campaign to make Scotland the first part of the UK to allow the practice.
The war in the Middle East is beginning to disrupt the flow of critical medicines to Gulf countries, raising concerns about the supply of cancer treatments and other temperature-sensitive drugs, according to pharmaceutical industry executives.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment